Current Ratio in % of Nascent Biotech Inc. from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nascent Biotech Inc. quarterly Current Ratio history and change rate from Q3 2015 to Q2 2024.
  • Nascent Biotech Inc. Current Ratio for the quarter ending 30 Jun 2024 was 76.7 %, a 160% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2024 76.7 +47.2 +160% 30 Jun 2024
Q1 2024 62.5 +33.1 +112% 31 Mar 2024
Q4 2023 45.4 +14.8 +48.4% 31 Dec 2023
Q3 2023 33.7 -3.75 -10% 30 Sep 2023
Q2 2023 29.6 +5.43 +22.5% 30 Jun 2023
Q1 2023 29.4 +0.22 +0.75% 31 Mar 2023
Q4 2022 30.6 -9.62 -23.9% 31 Dec 2022
Q3 2022 37.5 +12.3 +48.7% 30 Sep 2022
Q2 2022 24.1 -2.23 -8.46% 30 Jun 2022
Q1 2022 29.2 +10.1 +53% 31 Mar 2022
Q4 2021 40.2 +37.5 +1385% 31 Dec 2021
Q3 2021 25.2 +23.5 +1377% 30 Sep 2021
Q2 2021 26.4 +26.2 +14454% 30 Jun 2021
Q1 2021 19.1 +18.8 +6232% 31 Mar 2021
Q4 2020 2.71 -2.1 -43.7% 31 Dec 2020
Q3 2020 1.7 -7.6 -81.7% 30 Sep 2020
Q2 2020 0.18 -14.8 -98.8% 30 Jun 2020
Q1 2020 0.3 -18.6 -98.4% 31 Mar 2020
Q4 2019 4.8 -17.8 -78.7% 31 Dec 2019
Q3 2019 9.3 -34.5 -78.8% 30 Sep 2019
Q2 2019 15 -95.7 -86.4% 30 Jun 2019
Q1 2019 18.9 -132 -87.5% 31 Mar 2019
Q4 2018 22.6 -139 -86% 31 Dec 2018
Q3 2018 43.8 -83.9 -65.7% 30 Sep 2018
Q2 2018 111 -14.1 -11.3% 30 Jun 2018
Q1 2018 151 +114 +304% 31 Mar 2018
Q4 2017 161 +136 +540% 31 Dec 2017
Q3 2017 128 +110 +607% 30 Sep 2017
Q2 2017 125 +116 +1332% 30 Jun 2017
Q1 2017 37.3 +29.6 +385% 31 Mar 2017
Q4 2016 25.2 +22.4 +795% 31 Dec 2016
Q3 2016 18.1 +12.3 +215% 30 Sep 2016
Q2 2016 8.72 30 Jun 2016
Q1 2016 7.7 31 Mar 2016
Q4 2015 2.81 31 Dec 2015
Q3 2015 5.74 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.